Tokyo, April 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061398) titled 'A Retrospective Study of the Effects of Pemafibrate in Patients with Dyslipidemia Complicated by Metabolic Dysfunction-Associated Steatotic Liver Disease' on April 28.
Study Type:
Observational
Primary Sponsor:
Institute - Kagawa university
Condition:
Condition - Patients with dyslipidemia complicated by steatotic liver disease/MASLD
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to assess the clinical course following pemafibrate administration in patients with dyslipidemia complicated by MASLD who are regularly followed at our hospital, with co...